Advanced search
Publication Cover
Leukemia & Lymphoma Volume 54, 2013 - Issue 9
Submit an article Journal homepage
301
Views
25
CrossRef citations to date
0
Altmetric
Research Article

Pharmacokinetics and dose escalation of the heat shock protein inhibitor 17-allyamino-17-demethoxygeldanamycin in combination with bortezomib in relapsed or refractory acute myeloid leukemia

Alison R. WalkerDivision of Hematology, Department of Internal MedicineCorrespondence[email protected]
,
Rebecca KlisovicDivision of Hematology, Department of Internal Medicine
,
Jeffrey S. JohnstonCollege of Pharmacy
,
Yao JiangCollege of Pharmacy
,
Susan GeyerDivision of Hematology, Department of Internal Medicine
,
Cheryl KefauverClinical Trials Office, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA
,
Philip BinkleyDivision of Cardiovascular Medicine and the Dorothy M. Davis Heart and Lung Research Institute, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA
,
John C. ByrdDivision of Hematology, Department of Internal Medicine
,
Michael R. GreverDivision of Hematology, Department of Internal Medicine
,
Ramiro GarzonDivision of Hematology, Department of Internal Medicine
,
Mitch A. PhelpsCollege of Pharmacy
,
Guido MarcucciDivision of Hematology, Department of Internal Medicine;Department of Molecular, Cellular, and Developmental Biology, The Ohio State University and The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA
,
Kristie A. BlumDivision of Hematology, Department of Internal Medicine
&
William BlumDivision of Hematology, Department of Internal Medicine
 show all
Pages 1996-2002 | Received 01 Oct 2012, Accepted 17 Dec 2012, Published online: 24 Jan 2013

Citations (25)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Marte Karen Brattås, Håkon Reikvam, Tor Henrik Anderson Tvedt & Øystein Bruserud. (2019) Precision medicine for TP53-mutated acute myeloid leukemia. Expert Review of Precision Medicine and Drug Development 4:5, pages 263-274.
Read now
Hui-Jen Tsai, Neng-Yao Shih, Sung-Hsin Kuo, Ann-Lii Cheng, Hui-You Lin, Tsai-Yun Chen, Kung-Chao Chang, Sheng-Fung Lin, Jeffrey S. Chang & Li-Tzong Chen. (2015) AUY922 effectively targets against activated B cell subtype of diffuse large B-cell lymphoma and low-grade lymphoma cells harboring genetic alteration-associated nuclear factor-κB activation. Leukemia & Lymphoma 56:9, pages 2674-2682.
Read now
Muneera Al-Hussaini & John F DiPersio. (2014) Small molecule inhibitors in acute myeloid leukemia: from the bench to the clinic. Expert Review of Hematology 7:4, pages 439-464.
Read now

Articles from other publishers (22)

Sunny Kumar, Malini Basu & Mrinal K. Ghosh. (2022) Chaperone-assisted E3 ligase CHIP: A double agent in cancer. Genes & Diseases 9:6, pages 1521-1555.
Crossref
Richard J. Roberts, Logan Hallee & Chi Keung Lam. (2021) The Potential of Hsp90 in Targeting Pathological Pathways in Cardiac Diseases. Journal of Personalized Medicine 11:12, pages 1373.
Crossref
Raphaël Bonnet, Marielle Nebout, Carine Brousse, Frédéric Reinier, Véronique Imbert, Pierre Simon Rohrlich & Jean-François Peyron. (2020) New Drug Repositioning Candidates for T-ALL Identified Via Human/Murine Gene Signature Comparison. Frontiers in Oncology 10.
Crossref
Tiffany G. Chan, Edward O’Neill, Christine Habjan & Bart Cornelissen. (2020) Combination Strategies to Improve Targeted Radionuclide Therapy. Journal of Nuclear Medicine 61:11, pages 1544-1552.
Crossref
Ranjit K. Mehta, Sanjima Pal, Koushik Kondapi, Merna Sitto, Cuyler Dewar, Theresa Devasia, Matthew J. Schipper, Dafydd G. Thomas, Venkatesha Basrur, Manjunath P. Pai, Yoshihiro Morishima, Yoichi Osawa, William B. Pratt, Theodore S. Lawrence & Mukesh K. Nyati. (2020) Low-Dose Hsp90 Inhibitor Selectively Radiosensitizes HNSCC and Pancreatic Xenografts. Clinical Cancer Research 26:19, pages 5246-5257.
Crossref
Steven D. Green & Heiko Konig. (2020) Treatment of Acute Myeloid Leukemia in the Era of Genomics—Achievements and Persisting Challenges. Frontiers in Genetics 11.
Crossref
Fen Chen, Haiyang Xie, Haiwei Bao, Laurencia Violetta & Shusen Zheng. (2020) Combination of HSP90 and autophagy inhibitors promotes hepatocellular carcinoma apoptosis following incomplete thermal ablation. Molecular Medicine Reports.
Crossref
Neil Beeharry, Sean LandretteSophia GayleMarylens HernandezJeff E. GrotzkePeter R. YoungPaul BeckettXuan Zhang, Bing Z. Carter, Michael Andreeff, Stephanie Halene, Tian Xu, Jonathan RothbergHenri Lichenstein. (2019) LAM-003, a new drug for treatment of tyrosine kinase inhibitor–resistant FLT3-ITD–positive AML. Blood Advances 3:22, pages 3661-3673.
Crossref
Sangkyu Park, Jeong-A Park, Jae-Hyung Jeon & Younghee Lee. (2019) Traditional and Novel Mechanisms of Heat Shock Protein 90 (HSP90) Inhibition in Cancer Chemotherapy Including HSP90 Cleavage. Biomolecules & Therapeutics 27:5, pages 423-434.
Crossref
Sona Talaei, Hassan Mellatyar, Asadollah Asadi, Abolfazl Akbarzadeh, Roghayeh Sheervalilou & Nosratollah Zarghami. (2019) Spotlight on 17‐ AAG as an Hsp90 inhibitor for molecular targeted cancer treatment . Chemical Biology & Drug Design 93:5, pages 760-786.
Crossref
Maxim Shevtsov & Gabriele Multhoff. 2019. Chaperokine Activity of Heat Shock Proteins. Chaperokine Activity of Heat Shock Proteins 211 243 .
John C. Byrd. (2018) HSP90 inhibition without heat shock response. Blood 132:3, pages 241-242.
Crossref
Jialin Duan, Jingwen Tao, Maocai Zhai, Chengpeng Li, Ning Zhou, Jiagao Lv, Lin Wang, Li Lin & Rong Bai. (2018) Anticancer drugs-related QTc prolongation, torsade de pointes and sudden death: current evidence and future research perspectives. Oncotarget 9:39, pages 25738-25749.
Crossref
Jacqueline Cloos, Margot SF Roeten, Niels E Franke, Johan van Meerloo, Sonja Zweegman, Gertjan JL Kaspers & Gerrit Jansen. (2017) (Immuno)proteasomes as therapeutic target in acute leukemia. Cancer and Metastasis Reviews 36:4, pages 599-615.
Crossref
Sook-Kyoung Heo, Eui-Kyu Noh, Jeong Yi Kim, Yoo Kyung Jeong, Jae-Cheol Jo, Yunsuk Choi, SuJin Koh, Jin Ho Baek, Young Joo Min & Hawk Kim. (2017) Targeting c-KIT (CD117) by dasatinib and radotinib promotes acute myeloid leukemia cell death. Scientific Reports 7:1.
Crossref
Qiong Yang, Florian Puhm, Michael Freissmuth & Christian Nanoff. (2017) Hyponatremia and V2 vasopressin receptor upregulation: a result of HSP90 inhibition. Cancer Chemotherapy and Pharmacology 80:4, pages 673-684.
Crossref
C M Csizmar, D-H Kim & Z Sachs. (2016) The role of the proteasome in AML. Blood Cancer Journal 6:12, pages e503-e503.
Crossref
Shing M. LeeDaniel BackenrothYing Kuen Ken CheungDawn L. HershmanDiana VulihBarry AndersonPercy IvyLori Minasian. (2016) Case Example of Dose Optimization Using Data From Bortezomib Dose-Finding Clinical Trials. Journal of Clinical Oncology 34:12, pages 1395-1401.
Crossref
Jianbiao Zhou, Ying Qing Ching & Wee-Joo Chng. (2015) Aberrant nuclear factor-kappa B activity in acute myeloid Leukemia: from molecular pathogenesis to therapeutic target. Oncotarget 6:8, pages 5490-5500.
Crossref
Ansgar Brüning & Julia Jückstock. (2015) Misfolded Proteins: From Little Villains to Little Helpers in the Fight Against Cancer. Frontiers in Oncology 5.
Crossref
Victoria Zismanov, Liat Drucker & Maya Gottfried. (2014) Combined inhibition of Hsp90 and the proteasome affects NSCLC proteostasis and attenuates cell migration. Anti-Cancer Drugs 25:9, pages 998-1006.
Crossref
Jennifer Davila, Emily Slotkin & Thomas Renaud. (2013) Relapsed and Refractory Pediatric Acute Myeloid Leukemia: Current and Emerging Treatments. Pediatric Drugs 16:2, pages 151-168.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.